{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T16:03:17Z","timestamp":1697472197308},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1038\/bjc.2011.373","type":"journal-article","created":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T22:56:44Z","timestamp":1318373804000},"page":"1105-1106","source":"Crossref","is-referenced-by-count":3,"title":["Aspirin therapy for cancer: it is never too late"],"prefix":"10.1038","volume":"105","author":[{"given":"J A Z","family":"Jankowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P J","family":"Limburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,10,11]]},"reference":[{"issue":"6","key":"BFbjc2011373_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1001\/jama.2009.1112","volume":"302","author":"AT Chan","year":"2009","unstructured":"Chan AT, Ogino S, Fuchs CS (2009) Aspirin use and survival after diagnosis of colorectal cancer. JAMA 302 (6): 649\u2013658","journal-title":"JAMA"},{"issue":"5","key":"BFbjc2011373_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S1470-2045(09)70035-X","volume":"10","author":"J Cuzick","year":"2009","unstructured":"Cuzick J, Otto F, Baron JA, Brown PH, Burn J, Greenwald P, Jankowski J, La Vecchia C, Meyskens F, Senn HJ, Thun M (2009) Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol 10 (5): 501\u2013507","journal-title":"Lancet Oncol"},{"issue":"2","key":"BFbjc2011373_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1734-1140(10)70262-0","volume":"62","author":"N Ghosh","year":"2010","unstructured":"Ghosh N, Chaki R, Mandal V, Mandal SC (2010) COX-2 as a target for cancer chemotherapy. Pharmacol Rep 62 (2): 233\u2013244","journal-title":"Pharmacol Rep"},{"issue":"9","key":"BFbjc2011373_CR4","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1200\/JCO.2009.22.7918","volume":"28","author":"MD Holmes","year":"2010","unstructured":"Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE (2010) Aspirin intake and survival after breast cancer. J Clin Oncol 28 (9): 1467\u20131472","journal-title":"J Clin Oncol"},{"key":"BFbjc2011373_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/ncpgasthep0412","volume":"3","author":"J Jankowski","year":"2006","unstructured":"Jankowski J, Hawk E (2006) A methodological analysis of chemoprevention in the gastrointestinal tract. Nat Clin Pract Gastro Hep 3: 101\u2013111","journal-title":"Nat Clin Pract Gastro Hep"},{"key":"BFbjc2011373_CR6","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1158\/1055-9965.EPI-07-0710","volume":"17","author":"J Jankowski","year":"2008","unstructured":"Jankowski J, Hunt R (2008) Cyclooxygenase-2 inhibitors in colorectal cancer prevention; better the devil you know. Cancer Epidemiol Biomarkers Prevent 17: 1858\u20131861","journal-title":"Cancer Epidemiol Biomarkers Prevent"},{"issue":"15","key":"BFbjc2011373_CR7","first-page":"4399","volume":"48","author":"GA Kune","year":"1988","unstructured":"Kune GA, Kune S, Watson LF (1988) Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res 48 (15): 4399\u20134404","journal-title":"Cancer Res"},{"key":"BFbjc2011373_CR8","doi-asserted-by":"crossref","unstructured":"Langley RE, Burdett S, Tierney JF, Cafferty F, Parmar MKD, Venning G (2011) Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy? Br J Cancer (this issue)","DOI":"10.1038\/bjc.2011.289"},{"issue":"2","key":"BFbjc2011373_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2184.2006.00377.x","volume":"39","author":"JG Mahdi","year":"2006","unstructured":"Mahdi JG, Mahdi AJ, Mahdi AJ, Bowen ID (2006) The historical analysis of aspirin discovery, its relation to the willow tree and antiproliferative and anticancer potential. Cell Prolif 39 (2): 147\u2013155","journal-title":"Cell Prolif"},{"issue":"30","key":"BFbjc2011373_CR10","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1200\/JCO.2010.29.6244","volume":"28","author":"RS Midgley","year":"2010","unstructured":"Midgley RS, McConkey CC, Johnstone EC, Dunn JA, Smith JL, Grumett SA, Julier P, Iveson C, Yanagisawa Y, Warren B, Langman MJ, Kerr DJ (2010) Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial. J Clin Oncol 28 (30): 4575\u20134580","journal-title":"J Clin Oncol"},{"key":"BFbjc2011373_CR11","doi-asserted-by":"publisher","first-page":"c7326","DOI":"10.1136\/bmj.c7326","volume":"341","author":"P Moayyedi","year":"2010","unstructured":"Moayyedi P, Jankowski JA (2010) Does long term aspirin prevent cancer? BMJ 341: c7326","journal-title":"BMJ"},{"issue":"9759","key":"BFbjc2011373_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","volume":"377","author":"PM Rothwell","year":"2011","unstructured":"Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW (2011) Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 377 (9759): 31\u201341","journal-title":"Lancet"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2011373.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2011373","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2011373.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:03:37Z","timestamp":1684415017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2011373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["BFbjc2011373"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2011.373","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}